Cargando…
Complete remission of rare adenocarcinoma of the oropharynx with APCEDEN (®) (dendritic cell‐based vaccine): a case report
APCEDEN (®) is an autologous monocyte‐derived dendritic cell‐based immunotherapy. A 58‐year‐old man with adenocarcinoma of oropharynx shows complete remission after receiving APCEDEN (®) in conjunction with Geftinib validated by reduction in size, whereas Gefitinib alone lead to disease progression....
Autores principales: | Kumar, Chaitanya, Kohli, Sakshi, Chiliveru, Srikanth, Jain, Minish, Sharan, Bandana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628247/ https://www.ncbi.nlm.nih.gov/pubmed/29026574 http://dx.doi.org/10.1002/ccr3.1169 |
Ejemplares similares
-
Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN(®) in combination with chemotherapy
por: Kumar, Chaitanya, et al.
Publicado: (2019) -
Substantial tumor regression in prostate cancer patient with extensive skeletal metastases upon Immunotherapy (APCEDEN): A case report
por: Sharan, Bandana, et al.
Publicado: (2020) -
Tooth in oropharynx
por: Nagarajappa, D, et al.
Publicado: (2011) -
A case report of interdigitating dendritic cell sarcoma originating from the oropharynx
por: Oikawa, Shin‐ichi, et al.
Publicado: (2021) -
Gastric Choristoma of the Oropharynx
por: Chang, Hyun, et al.
Publicado: (2009)